http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0236105-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d1024a48ade195e740c6be211b36b54f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a6aee14919c5104c5d44936460f922f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ea0c145189517df2104d2e86ff0bcd1b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b8be6a6c990669567cc455d32b00535e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-724
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-724
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
filingDate 2001-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b6fef2fdfce502ab60d0a57a8bab46a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23c21232b2b8530df2178b7957b0e07e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e38c1ae73b854c653943a4e11be1cb68
publicationDate 2002-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0236105-A3
titleOfInvention Use of cortisol-sequestering agents for the treatment of hypercortisolaemia related disorders
abstract The invention relates to the use of cortisol-sequestering agents for the preparation of a medicament for the treatment of hypercortisolaemia related disorders, especially for the treatment of major depression; to pharmaceutical compositions comprising a cortisol-sequestering agent, and to the cortisol-sequestering agent 6-per-deoxy-6-per-(2,3-dihydroxypropylthio)-η-cyclodextrin.
priorityDate 2000-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9854221-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2109381-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0447171-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0140316-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H01153961-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6090794-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4814333-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396196
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5754

Total number of triples: 37.